The Trulicity pen -- an injectable drug for patients to manage their type 2 diabetes -- has been around for quite some time. According to Drugs.com, the medication was first approved by the U.S. Food ...
New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback